Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. Total Liabilities 2020–2025
Adma Biologics Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Adma Biologics Inc. total liabilities as of December 31, 2025: 146.9M, a 5.20% increase year-over-year.
- Adma Biologics Inc. total liabilities for 2025 were 146.9M, a 5.20% increase from 2024.
- Adma Biologics Inc. total liabilities for 2024 were 139.7M, a 28.00% decrease from 2023.
- Adma Biologics Inc. total liabilities for 2023 were 194.0M, a 1.28% decrease from 2022.
- Adma Biologics Inc. total liabilities for 2022 were 196.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Adma Biologics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $147 |
| 2024 | $140 |
| 2023 | $194 |
| 2022 | $196 |
| 2021 | $135 |
| 2020 | $119 |
Adma Biologics Inc. Total Liabilities — FAQ
Adma Biologics Inc. (ADMA) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADMA's total liabilities history?
The chart and table above show Adma Biologics Inc.'s total liabilities by year and by quarter, including the growth rate.